A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Bioasis Technologies Inc (CVE:BTI) (OTCQB:BIOAF) has announced the publication of research validating the ability of its xB3 platform to cross the intact blood-brain barrier (BBB) and its localization in a variety of brain cell types. The company said research shows that the xB3 platform can cross intact BBB and enter intracellular organelles within neurons, glia and microglia in the brain. It said the data from a study published on June 2 in the Frontiers in Neuroscience provide evidence for the utility of xB3 peptide (previously known as MTfpep) as a platform technology for delivery of recombinant and chemically conjugated drug across the BBB.
Industry Looks at Ways to Sustain Growth After Pandemic sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
First Posted: May 07, 2021 04:44 AM EDT
Photo : Photo by Frazer Harrison/Getty Images
To help schools eyeing a return to in-person classes, San Diego biotech Biocept is bringing coronavirus testing to community colleges throughout the state of California.
The company recently announced a testing partnership with the Foundation for California Community Colleges, a nonprofit group that supports 116 community colleges in the area, serving more than 2 million students. The included schools will be able to administer coronavirus tests to students and staff, send samples to the local lab of Biocept and receive results within 48 hours.
According to The San Diego Union-Tribune, Biocept CEO Michael Nall stated that biotech started to offer coronavirus testing around last year after the company realized that it had the equipment, expertise, and laboratory certifications to run the tests. He also added that Biocept started to use a test made by Thermo Fisher to detect genetic material from